Names and pronunciation
(em′i-siz′ue-mab) Hemlibra
PDF page 459
Drug reference
(em′i-siz′ue-mab) Hemlibra
PDF page 459
Func. class.: Antibody IgG4
PDF page 459
USES: For routine bleeding prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors
PDF page 459
CONTRAINDICATIONS E Hypersensitivity
PDF page 459
DOSAGE AND ROUTES • Adult and child: SUBCUT: 3 mg/kg/ dose weekly for the first 4 wk, then a maintenance dose of 1.5 mg/kg/dose, weekly, 3 mg/kg/dose weekly every 2 wk, or 6 mg/kg/dose q4wk.
PDF page 459
Available forms: Injection 30 mg/mL, 60 mg/0.4 mL, 105 mg/0.7 mL, 150 mg/mL single dose
PDF page 459
• Adult and child: SUBCUT: 3 mg/kg/ dose weekly for the first 4 wk, then a maintenance dose of 1.5 mg/kg/dose, weekly, 3 mg/kg/dose weekly every 2 wk, or 6 mg/kg/dose q4wk.
PDF page 459